Skip to Content
No Fees Unless We Win 855-948-5098
Cymbalta Withdrawal Client Focused. Trial Ready. Billions Won.

Cymbalta® Withdrawal

What is Cymbalta Withdrawal?

Cymbalta withdrawal refers to the symptoms a person experiences when they stop taking Cymbalta, also called discontinuation-emergent adverse events (“DEAEs”).

The frequency of Cymbalta withdrawal is associated with a drug’s “half-life.” The term “half-life” means the amount of time it takes for half of the drug to be eliminated from the body after one stops taking it. In his book, The Antidepressant Solution, Dr. Joseph Glenmullen, a clinical instructor in psychiatry 

​at Harvard, explains that “the frequency with which antidepressants cause withdrawal reactions correlates with how short their half-lives are.” When a drug has a short half-life, the drug begins to exit the patients system very quickly, and that sudden depletion of the drug in the patient’s body, leads to withdrawal. Conversely, drugs that have a long half-life, leave the body gradually and generally have less frequent and severe withdrawal effects.

Common side effects of Cymbalta withdrawal:

  • Extreme mood swings
  • Agitation and/or irritability
  • Aggression
  • Nightmares and/or sleep disturbance
  • Confusion
  • Diarrhea
  • Vertigo
  • Dizziness and/or light-headedness
  • Headache and/or migraines
  • Nausea and/or vomiting
  • Excessive sweating
  • Memory and concentration difficulties
  • Suicidal thoughts (ideation)
  • Suicide attempts
  • Self-mutilation
  • Hallucination and/or sensory disturbances
  • Tremors
  • Seizures
  • Fatigue
  • Lethargy
  • Flu-like symptoms (abdominal discomfort, weakness, etc.)
  • Body zaps – electronic shock-like sensations in body (not in head)
  • Brain zaps – electric shock-like sensations in head

Cymbalta Half-Life

Cymbalta has an extremely short half-life of about twelve hours. This means that, on average, when taking Cymbalta, half of the drug leaves the patient’s system within twelve hours. This is an extremely fast rate. And, among antidepressants, Cymbalta is the second fastest. With such a short half-life, you would expect Cymbalta users to experience very high rates of withdrawal effects. You would also hope that the manufacturer of Cymbalta would properly warn patients and their physicians about this serious risk through the drug label and in Cymbalta advertising.

We are no longer accepting Cymbalta cases.

How Severe are Cymbalta Withdrawal Effects?

According to Lilly’s own clinical trials, in many cases, Cymbalta withdrawal reactions were moderate to severe. In the short term trials, one out of every ten patients experienced severe reactions. In one 52-week trial, at least one in six patients was severely affected. In another study, 25% of those who experienced withdrawal effects had severe reactions.

In 2008, the Annals of Clinical Psychiatry published a report of a 26-year-old woman who was so traumatized by the nausea, dizziness, and “electric shocks inside the head” when she tried to withdraw from Cymbalta that she requested to be put on another antidepressant immediately and “expressed a real fear of having these shock-like reactions again.” The authors observed that, “Antidepressants with a short half-life tend to be associated with a significant rate of DEAEs and a higher severity level” (emphasis added).

Cymbalta withdrawal effects, including extreme mood swings (anger, irritability), debilitating brain zaps, and physical and neurological problems, can be severe and extend for weeks and even months. The volume of patient complaints and the severity of the symptoms reported on multiple websites (including on such websites as the People’s Pharmacy and Depression Forums) leaves little doubt about the seriousness of Cymbalta withdrawal. In many patients, Cymbalta creates what amounts to a physical dependence that makes it nearly impossible to quit taking the drug.

We are no longer accepting Cymbalta cases.

How Long Does Cymbalta Withdrawal Last?

Like with any patient, the time it takes for a patient to stop experiencing withdrawal depends on the patient. According to Lilly’s own analysis of the Cymbalta studies, after a two week withdrawal period, over 50% of patients were still experiencing withdrawal side effects. Just how long the withdrawal effects lasted for those patients is unknown because Lilly never evaluated the effects of Cymbalta withdrawal beyond two weeks. This means patients and doctors have no idea just how long Cymbalta withdrawal could last.

Lilly’s conduct with respect to Cymbalta withdrawal is particularly suspect given that it was Lilly that orchestrated a campaign to promote Prozac as superior to other competing antidepressants such as Paxil and Zoloft based on the fact that Prozac had a long half-life and, thus, less frequent or severe withdrawal symptoms. While Lilly conducted studies in the 1990s comparing withdrawal rates of Prozac against other antidepressants in order to illustrate how much better Prozac was compared to the other antidepressants, Lilly never conducted similar studies of Cymbalta. Lilly knew, based on its research regarding Prozac, that with Cymbalta’s very short half-life, the drug would no doubt be associated with a high rate of withdrawal symptoms.

  • $63 Million Settlement Paxil Pediatric Class Action

    $63 million pediatric class action re false promotion of Paxil. Judge approves final terms of improved national pediatric paxil class action settlement – consumers get a better deal.

  • $40 Million Settlement Third-Party Payer Class Action

    $40 million third-party payer class action re off-label promotion of Paxil. Judge approves $40 million settlement in the second phase of national pediatric paxil class action – insurance companies to be reimbursed.

  • $28 Million Settlement Defective Drug Class Action

    $28 million Paxil defective drug class action. A class action has been brought in the US territory of Puerto Rico against UK-based drug major GlaxoSmithKline.

  • $10 Million Settlement Celexa-Lexapro Pediatric Class Action

    $10 million pediatric class action re false promotion of Celexa and Lexapro. Babies born to women who have used Lexapro and other similar medications such as Zoloft, Celexa, Prozac, Paxil, and Symbyax are at an increased risk for birth defects.

  • $9 Million Settlement Drug Injury

    Wisner Baum obtained a $9 million settlement on behalf of an individual who was injured by a drug.

Client-Focused Representation


We believe our track record speaks for itself. But you don’t have to take our word for it. See what our clients have to say about working with us.

    "I Can’t Imagine a Better Law Firm"

    Multiple lawyers recommended Wisner Baum to me and I have been consistently impressed with the quality of their work.

    - Best Law Firms Survey
    "They Are About Changing the Systems..."

    Wisner Baum are not only amazing attorneys but more importantly, they are activists. They are about changing the systems which got us into trouble in the first place. They understand their role in the process of making change.

    - Kim Witczak
    "Top Legal Minds in the Country"

    The Wisner Baum firm has some of the top legal minds in the country; they are driven, determined, trustworthy, ethical and passionate.

    - From Best Lawyers® Best Law Firms
Nationwide Legal Advocacy Call (855) 948-5098 to Learn About Your Legal Options Free & Confidential Consultation